Bionano Genomics
BNGO | NASDAQ
$0.94
-$0.06 (-6.00%)
At close: Nov 16, 2026, 4:00 PM ET
$0.99
+$0.05 (+5.32%)
After-hours:
Nov 16, 2026, 7:51 PM ET
-6.00%
(1D)Rating
49.8
Fundamentals Average
Market Sentiment Neutral
Moat None
Sector Rank #282/1021 (Top 28%)
Key Statistics
Market Data
Market Cap $13.14M
1D Range
0.93 1.00
52W Range
0.93 1.85
Valuation (TTM)
PE -0.35
PB 0.47
EV/EBITDA -0.67
Valuation (NTM)
Forward PE N/A
Forward PEG 0.01
Price Target $5.00
Cash Flow
FCF Yield -145.2%
SBC Adj. FCF Yield -167.0%
SBC Impact -15.0%
Margins
Gross Margin 48.0%
Operating Margin -97.1%
FCF Margin -61.4%
Growth (CAGR)
Revenue 3Y | 5Y -2.6% |
14.7%
Dil EPS 3Y | 5Y 130.0% |
54.1%
FCF 3Y | 5Y 85.5% |
40.8%
Returns
ROA -65.0%
ROE -85.0%
ROIC -86.6%
Financial Health
Net Cash
$4.36M
Current Ratio 2.07
Interest Coverage -144.44
Dividends
Div Yield N/A
Payout Ratio N/A
FCF Payout Ratio N/A
Loading financial charts...
Profile
Bionano Genomics, Inc. focuses on providing advanced solutions for analyzing genomes. The company's flagship offering is Saphyr, a complete system that processes samples to results, enabling the analy...
Sector Healthcare
Industry Medical - Instruments & Supplies
Employees 96
IPO Date Aug 21, 2018
Website bionano.com
Fiscal Year January - December
Latest News
No news articles available yet.
Earnings
Latest Earnings
Nov 10, 2026
EPS
-$0.54
Miss -20.00%
YoY:
+66.04% REV
$8.28M
Miss -1.98%
YoY:
+12.34%Next Earnings
Mar 22, 2027
EPS Est
Pro
Rev Est
Pro
Analyst Summary
# of Analysts
1
Consensus
Buy
Price Target
$5.00
Upside
+431.91%
Buy (1)
Hold (0)
Sell (0)
Add to Watchlist
Select watchlists to add or remove BNGO